DRUG · Unmapped registry intervention
Levodopa-Carbidopa Intestinal Gel (LCIG)
Find medicine records ·
Find other trials using this name
Clinical trial
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
NCT00660673
Study summary
ClinicalTrials.govOpen Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DEVICE · Unmapped registry intervention
CADD-Legacy® 1400 ambulatory infusion pump
Find medicine records ·
Find other trials using this name
DEVICE · Unmapped registry intervention
Percutaneous Endoscopic Gastrostomy with jejunal extension tube (PEG-J)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Advanced Parkinson's Diseaseunresolved
Interventions
Sponsors & collaborators
AbbVielead sponsor
IQVIA, formerly Quintilescollaborator
Mapped research locations
Saint PetersburgRussia3New YorkNew York, United States2ChicagoIllinois, United States2BaltimoreMaryland, United States2PragueCzechia2BangkokThailand2Los AngelesCalifornia, United States1St LouisMissouri, United States1TorontoOntario, Canada1LondonUnited Kingdom1ClevelandOhio, United States1BirminghamAlabama, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00660673 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.